Management of resistant arterial hypertension: specialized center health management
International Journal of Development Research
Management of resistant arterial hypertension: specialized center health management
Received 20th February, 2022; Received in revised form 17th March, 2022; Accepted 09th April, 2022; Published online 27th May, 2022
Copyright © 2022, Luciana da Costa Nogueira Cerqueira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Resistant Arterial Hypertension (RAH) is a health condition of high cardiovascular risk that compromises the quality of life and the health system as a whole; in addition, there are subgroups with a greater relationship with morbidity and mortality, which requires greater attention in the clinical management. Effective and targeted Public Health Policies favor the control and improvement of the quality of life of this population, however, there is still an important gap in access to specialized programs and strategies that provide targeted assistance to patients with RAH. The present study comprises an integrative literature review, which aims to seek and analyze evidence about programs carried out in reference centers specialized in the care of patients with RAH. After an exhaustive literature search, the sample included 04 studies developed in Europe and with a low level of evidence. In the synthesis, two major thematic categories were evidenced, namely, physical activity in the control of resistant arterial hypertension using combined aerobic and strength exercise and the monitoring and follow-up of antihypertensive therapy, aimed at improving pharmacological compliance by single-pill therapy and patient-directed health education and follow-up. The strategies proved to be alternatives for the care provided to resistant hypertensive patients in reference centers by an interdisciplinary team, an important ally in maintaining the quality of life of this population, reducing morbidity and mortality and conscious and targeted control of health-related costs.